The most common side effects of OPDIVO when used in combination with cabozantinib include: diarrhea feeling tired or weak liver problems rash, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet mouth sores rash high blood pressure low thyroid hormone levels ...
Overall survival was not reached in either the Opdivo + Cabometyx (cabozantinib) group or the Sutent group during the 18.1 months median follow up period Median duration of response Opdivo + Cabometyx: 20.2 months (95% CI 17.3, not reached) ...
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation. Cancer 2018, 124, 306–314. [Google Scholar] [CrossRef] [PubMed] Jimbo, T.; Taira, T.; Komatsu, T.; Kumazawa, K.; Maeda, N.; Haginoya,...